Soy shake	Control	Center for Epidemiologic Studies Depression Scale score	1182	1340	CES-D scores decreased in the soy group by 16% (P = .004) and in the placebo group by 15% (P = .05). The change in scores was similar in the groups (P = .83).
Soy shake	Control	Fibromyalgia Impact Questionnaire scores	899	1072	Use of standard statistics with intent-to-treat analysis showed that total FIQ scores decreased by 14% in the soy group (P = .02) and by 18% in the placebo group (P < .001).
Soy shake	Casein shake (Placebo)	Center for Epidemiologic Studies Depression Scale score	12949	13077	With intent-to-treat analysis, the CES-D scores improved 16% (±26) in the soy group and 15% (±41) in the placebo group (P = .83)
Soy shake 	Casein shake (Placebo)	Fibromyalgia Impact Questionnaire scores	968	1159	total FIQ scores decreased by 14% in the soy group (P = .02) and by 18% in the placebo group (P < .001). The difference in change in scores between the groups was not significant (P = .16). W
Soy shake	Casein shake (Placebo)	Center for Epidemiologic Studies Depression Scale score	1182	1340	CES-D scores decreased in the soy group by 16% (P = .004) and in the placebo group by 15% (P = .05). The change in scores was similar in the groups (P = .83).
Soy shake	Control	Fibromyalgia Impact Questionnaire scores	899	1156	Use of standard statistics with intent-to-treat analysis showed that total FIQ scores decreased by 14% in the soy group (P = .02) and by 18% in the placebo group (P < .001). The difference in change in scores between the groups was not significant (P = .16)
Soy shake 	Casein shake (Placebo)	Fibromyalgia Impact Questionnaire scores	12490	12674	With intent-to-treat analysis, the total FIQ scores determined at study entry and at study completion decreased 14% (±29) in the soy group and 18% (±25) in the placebo group (P = .16).
